1 not yet recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Not yet recruiting 1 |
Follow cGVHD: new trials by email Literature Review of cGVHD trials Research Report on cGVHD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Anti-CD25 rhMAb in the Treatment of Steroid-Refractory cGVHD anti-CD25 rhMAb, Prednisone, Ruxolitinib - cGVHD | Phase 4 | Not yet recruiting | Peking University People's Hospital | 30 | 2026-07-15 | 2026-06-18 |
Cyclosporine (1) · Prednisone (1) · ruxolitinib (1)